ImmunityBio IBRX
NASDAQ IBRX
$8.07 -0.11 (-1.40%)
As of: Sep 4, 2026 · 3:59 PM EDT

ImmunityBio (IBRX) Goodwill (2024 - 2026)

ImmunityBio (IBRX) posted quarterly Goodwill of $910000.0 for Q1 2026, little changed year-over-year from $910000.0 in Q1 2025, and little changed quarter-over-quarter from $910000.0 in Q4 2025.

Analysis

ImmunityBio (IBRX) Goodwill (2024 - 2026) Analysis & Trends

ImmunityBio (IBRX) has reported Goodwill for 3 consecutive years, with $910000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill changed 0.0% year-over-year to $910000.0; the TTM figure through Mar 2026 stood at $910000.0 (changed 0.0% YoY), while the FY2025 annual figure was $910000.0, changed 0.0% from the prior year.
  • Goodwill held at $910000.0 in Q1 2026 per IBRX's latest filing, from $910000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $910000.0 in Q4 2024 and bottomed at $900000.0 in Q3 2024.
  • Historically, Goodwill has averaged $908571.4 across 3 years, with a median of $910000.0 in 2024.
  • On a YoY basis, Goodwill climbed as much as 1.11% in 2025 and fell as far as 0.0% in 2025.
  • ImmunityBio's Goodwill stood at $910000.0 in 2024, then changed by 0.0% to $910000.0 in 2025, then changed by 0.0% to $910000.0 in 2026.
  • Business Quant data shows IBRX's Goodwill at $910000.0 in Q1 2026, $910000.0 in Q4 2025, and $910000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 ImmunityBio 8.51 Bn 8.15 Bn 50.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 910,000.00
Dec 31, 2025 910,000.00
Sep 30, 2025 910,000.00
Jun 30, 2025 910,000.00
Mar 31, 2025 910,000.00
Dec 31, 2024 910,000.00
Sep 30, 2024 910,000.00